c&en: Ollin eyes ophthalmologic diseases with $100 million launch - Ollin Bio

Ollin Bio

About Us
Therapeutic Areas
Pipeline
Team
News
Careers

09/17/2025

Share

Home
Privacy Policy
Terms of Use